Cargando…
Can the disease course in Parkinson’s disease be slowed?
BACKGROUND: The diagnosis of Parkinson’s disease (PD), which is needed for useful symptomatic therapy, is based on clinical criteria. However, it became quite clear in recent years that the same features can occur through different etiopathogenic mechanisms. Even a pathological diagnosis of PD, base...
Autores principales: | Korczyn, Amos D., Hassin-Baer, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675014/ https://www.ncbi.nlm.nih.gov/pubmed/26653056 http://dx.doi.org/10.1186/s12916-015-0534-x |
Ejemplares similares
-
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
por: Jellinger, Kurt A., et al.
Publicado: (2018) -
Drug treatment of Parkinson's disease
por: Korczyn, Amos D.
Publicado: (2004) -
Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report
por: Bordet, Régis, et al.
Publicado: (2017) -
Editorial comments: treatment of motor fluctuations in Parkinson’s disease
por: Korczyn, Amos D.
Publicado: (2011) -
Capturing Subjective Mild Cognitive Decline in Parkinson’s Disease
por: Rosenblum, Sara, et al.
Publicado: (2022)